Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral presentation of XYLO study ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jazz Pharmaceuticals is pressing pause on a phase 1 sleep disorder med due to adverse events despite one executive saying that it “achieved proof of concept.” The comments were relayed by Chief ...

Axsome Therapeutics, Inc. AXSM announced that it has entered into a definitive agreement with Jazz Pharmaceuticals JAZZ to acquire the latter’s new sleep drug, Sunosi (solriamfetol). The drug is ...

Jazz Pharmaceuticals is stepping up its support for the American Heart Association (AHA). Through the expanded relationship, the AHA will bang the drum about the links between sleep disorders and ...